Cointime

Confo Therapeutics

company

About

Confo Therapeutics is a drug discovery company building internal drug discovery programs on GPCRs addressing unmet medical need.

  • 51 - 100

Highlights

Total Funding Amount
€1.60M
Funding Rounds
1
Investors
1

Details

Last Funding Type
Grant
Last Funding Money Raised
€1.60M
Industries
Biotechnology,Health Care,Medical,Therapeutics
Founded date
Jan 1, 2015
Number Of Employee
51 - 100
Operating Status
Active

Confo Therapeutics is a drug discovery company building internal drug discovery programs on GPCRs addressing unmet medical need. Confo Therapeutics employs its proprietary CONFO® technology to lock inherent unstable functional conformations of GPCRs as a superior starting point for drug discovery. CONFO® body-stabilized active state conformations of these receptors disclose previously inaccessible structural features empowering the discovery of novel agonists for better therapeutic intervention.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
€1.60M
Confo Therapeutics has raised a total of €1.60M in funding over 2 rounds. Their latest funding was raised on Feb 3, 2017 from a Grant round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Feb 3, 2017 Grant €1.60M 1 The Institute for the Promotion of Innovation by Science and Technology in Flanders — Detail

Investors

Number of Lead Investors
Number of Investors
1
1
Confo Therapeutics is funded by 1 investors. The Institute for the Promotion of Innovation by Science and Technology in Flanders are the most recent investors.
Investor Name Lead Investor Funding Round
The Institute for the Promotion of Innovation by Science and Technology in Flanders Yes Grant
Cointime
เนื้อหา
บริษัท